Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2522278 | 0.94 | CYP3A4 (0.50) | TSHRCYP3A4ALDH1A1PLA2G2CLPAR3 | |
| SCHEMBL20466177 | 0.92 | TSHR (0.45) | TSHRCYP3A4ALDH1A1PLA2G2CLPAR3 | |
| SCHEMBL2518477 | 0.91 | TSHR (0.44) | TSHRCYP3A4ALDH1A1LPAR3LPAR1 | |
| SCHEMBL17164135 | 0.88 | CYP3A4 (0.62) | TSHRCYP3A4PLA2G2CLPAR3LPAR1 | |
| SCHEMBL28044773 | 0.88 | TSHR (0.41) | TSHRCYP3A4ALDH1A1LPAR3LPAR1 | |
| SCHEMBL2598173 | 0.88 | CYP3A4 (0.45) | TSHRCYP3A4ALDH1A1PLA2G2CLPAR3 | |
| SCHEMBL11591195 | 0.87 | TSHR (0.41) | TSHRCYP3A4ALDH1A1LPAR3LPAR1 | |
| SCHEMBL2598056 | 0.85 | TSHR (0.40) | TSHRCYP3A4ALDH1A1LPAR3LPAR1 | |
| SCHEMBL23001188 | 0.85 | LPAR3 (0.58) | TSHRCYP3A4PLA2G2CLPAR3LPAR1 | |
| SCHEMBL14584196 | 0.85 | TSHR (0.45) | TSHRCYP3A4ALDH1A1LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129353-B1 | METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2024-02-28 | — | — | EP | disclosed |
| US-10294198-B2 | Method for producing xylylene diisocyanates in the gaseous phase | COVESTRO DEUTSCHLAND AG (DE) | 2019-05-21 | — | — | US | disclosed |
| US-10252988-B2 | Composition for producing transparent polythiourethane bodies | COVESTRO DEUTSCHLAND AG (DE) | 2019-04-09 | — | — | US | disclosed |
| EP-3129352-B1 | METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2017-11-15 | — | — | EP | disclosed |
| US-20170210702-A1 | METHOD FOR PRODUCING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2017-07-27 | — | — | US | disclosed |
| US-20170121449-A1 | COMPOSITION FOR PRODUCING TRANSPARENT POLYTHIOURETHANE BODIES | MITSUI CHEMICALS, INC. (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3129352-A1 | COMPOSITION CONTAINING AROMATIC NITRILES FOR THE PRODUCTION OF TRANSPARENT POLYTHIOURETHANE BODIES | Covestro Deutschland AG (DE) | 2017-02-15 | — | — | EP | disclosed |
| EP-3129353-A1 | COMPOSITION FOR PRODUCING TRANSPARENT POLYTHIOURETHANE BODIES | Covestro Deutschland AG (DE) | 2017-02-15 | — | — | EP | disclosed |
| EP-3129351-A2 | METHOD FOR PRODUCING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | Covestro Deutschland AG (DE) | 2017-02-15 | — | — | EP | disclosed |
| US-20170029552-A1 | COMPOSITION CONTAINING AROMATIC NITRILES FOR THE PRODUCTION OF TRANSPARENT POLYTHIOURETHANE BODIES | COVESTRO DEUTSCHLAND AG (DE) | 2017-02-02 | — | — | US | disclosed |
| WO-2015155366-A1 | COMPOSITION FOR PRODUCING TRANSPARENT POLYTHIOURETHANE BODIES | BAYER MATERIALSCIENCE AG (DE) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015155367-A1 | COMPOSITION CONTAINING AROMATIC NITRILES FOR THE PRODUCTION OF TRANSPARENT POLYTHIOURETHANE BODIES | BAYER MATERIALSCIENCE AG (DE) | 2015-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10252988-B2 | Composition for producing transparent polythiourethane bodies | PHOSPHO1, PCTP, AGPAT5 | TSHR 2486/4885CYP3A4 2713/4885ALDH1A1 2830/4885 |
| US-10294198-B2 | Method for producing xylylene diisocyanates in the gaseous phase | DCXR, DAD1, PAG1 | TSHR 4447/4885CYP3A4 715/4885ALDH1A1 2050/4885 |
| US-20170210702-A1 | METHOD FOR PRODUCING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | DCXR, DAD1, PAG1 | TSHR 4447/4885CYP3A4 715/4885ALDH1A1 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.